Targeted Treatment of Lung Cancer using Nanomaterials: Prospective and Advances

Background: Lung cancer is the second most lethal type of cancer, with a poor survival rate of 5 years. It is one of those malignant tumors that has grown most rapidly in the context of mortality and morbidity. Aim: This review article aims to provide insight into current nanotechnological approaches taken into consideration that provide advantages over conventional chemotherapy. Results and Discussion: After comparing conventional chemotherapy and nanotechnology-based therapies for lung cancer, the results showed that recent advances in nanomaterials proved to be more effective in lung cancer diagnosis, mitigation and treatment. Here, Surface-engineered smart nanocarrier- based inhalations, Bio-nanocarriers for lung cancer, gas plasma nanoparticles, and magnetic nanoparticles are discussed. Conclusion: After summarizing these nanomaterials, investigators concluded that the in-vivo and invitro effectiveness of recently developed nanoparticles was found to be better than that of conventional nanoparticles.